In this post, we’ll highlight a few of our favorite visuals from 2025 and walk through how we made them and what makes them ...

Editas Medicine has decided to end the development of its gene-editing therapy for thalassaemia and sickle cell disease (SCD), narrowing its R&D focus and making sweeping cuts to its workforce. After ...

The study presents convincing quantitative evidence, supported by appropriate negative controls, for the presence of low-abundance glycine receptors (GlyRs) within inhibitory synapses in telencephalic ...

Discover how the bearish harami pattern signals reversals in uptrends. Learn about its key components and strategies to ...

This scheme has consistently delivered the best returns in its Large & Mid-Cap category across .

This study reports a valuable method to predict the capacity of a candidate probiotic bacterium to metabolically outcompete a bacterial pathogen in the ecological niche of the murine respiratory tract ...